Eurizon SLJ Capital 13F Reveals Q1 Positions

Eurizon SLJ Capital Ltd filed a Form 13F on May 6, 2026 that reports its long US-equity positions as of March 31, 2026, per the SEC filing and Investing.com summary (Investing.com, May 6, 2026). The filing, submitted within the 45-day statutory window for quarter-end reporting, provides a snapshot of the manager's disclosed long exposure across sectors and key large-cap names. The 13F shows a total disclosed long market value of approximately $1.23 billion and a concentration in five sectors that together represent roughly 79% of disclosed value (SEC EDGAR; Investing.com). Those sector weights and security-level positions offer a high-frequency data point on positioning that institutional investors use to triangulate momentum flows and peer alignment. This piece breaks that filing into context, data deep dive, sector and risk implications, and concludes with a Fazen Markets perspective.

Context

Form 13F filings are a regulatory requirement for institutional investment managers with investment discretion over at least $100 million in 13(f) securities; they report positions in exchange-listed equities and certain convertibles as of quarter end (SEC, Rule 13f-1). Eurizon SLJ's May 6 filing covers holdings as of March 31, 2026 and was posted within the permissible 45-day reporting window, making it contemporaneous with other Q1 disclosures and useful for quarterly cross-sectional comparisons. The timing matters: May filings arrive ahead of first-quarter earnings season for many US corporates, so 13F disclosures can pre-announce strategic tilts — for example, overweighting technology ahead of chip-equipment results or trimming cyclical industrials before macro updates. Institutional investors, allocators, and corporate strategists routinely use 13Fs to infer relative momentum and conviction among managers, even though filings exclude short positions and intraday trades.

This 13F should be viewed as a partial, lagged signal rather than a definitive statement of current exposures. 13Fs report long positions only and are static as of quarter end; intramonth rebalancing, use of derivatives, and off-market exposures can materially change actual risk taken since March 31. Nevertheless, the filing adds degree of transparency: it lists position sizes by market value, enabling calculations of weight and turnover when compared to prior 13Fs. For Eurizon SLJ specifically, the disclosure complements public communications from the firm and peer filings, offering a triangulated read on how European asset managers—operating under different regulatory and client constraints—are positioning in US-listed growth and value names.

For context relative to peers, the average US-focused active manager in the same cohort typically reports double-digit percentage allocations to technology in Q1 2026; Eurizon SLJ’s reported tech weight (detailed below) aligns with that trend but shows subtle differences in stock selection and capitalization. That nuance is key for institutional investors conducting peer-performance attribution or for corporates evaluating shareholder bases ahead of strategic votes.

Data Deep Dive

The 13F lists 73 positions with a total disclosed long market value of about $1.23 billion as of March 31, 2026 (SEC EDGAR; Investing.com summary, May 6, 2026). Technology accounted for ~34.2% of disclosed value, financials ~18.1%, healthcare ~12.4%, consumer discretionary ~9.7%, and industrials ~4.6% — the top five sectors adding up to ~79% of the filing's total. At the security level, the largest reported holdings were concentrated in mega-cap U.S. equities: Apple (AAPL), Microsoft (MSFT), NVIDIA (NVDA), and Amazon (AMZN) were among the top-weighted names, collectively representing an estimated 28% of disclosed value. These concentrations reflect common passive-like tilts among active managers that retain benchmark-influenced exposures while pursuing idiosyncratic alpha.

Quarter-on-quarter comparisons reveal rotation within the disclosed portfolio. Compared with the December 31, 2025 filing, Eurizon SLJ increased its disclosed technology weight by approximately 6.2 percentage points, while trimming cyclical industrial exposure by ~3.0 percentage points (source: SEC 13F filings, Q4 2025 vs Q1 2026). Year-over-year, tech exposure is up roughly 11 percentage points versus Q1 2025, a meaningful shift that tracks broader industry flows into AI-enabled semiconductor and software names during the 12 months ending March 31, 2026. These directional moves correlate with sector performance: the S&P 500 Information Technology sector returned +18.6% in the trailing 12 months to March 31, 2026 versus +6.9% for Industrials (S&P Dow Jones Indices).

Turnover signals in the filing indicate selective rebalancing rather than wholesale rotation. Approximately 16 positions were initiated or materially increased in Q1, while 12 smaller positions were fully disposed of or reduced below the reporting threshold. The average position size among disclosed names is $16.8 million; the median is materially lower, suggesting a handful of concentration positions are carrying the headline market-value figure. These microstructure details help explain why headline totals may overstate the breadth of conviction: a large top-5 block can dominate portfolio exposures and performance contribution.

Sector Implications

Eurizon SLJ’s elevated technology weight has direct implications for sector-linked supply-chain beneficiaries and for benchmark-relative performance. A 34.2% tech weight increases the manager's sensitivity to earnings revisions in semiconductors and enterprise software. For example, stronger-than-expected guidance from NVDA or chip-equipment suppliers could meaningfully lift the filing's reported positions, while an earnings miss would have outsized negative impact. Conversely, the reduced allocation to industrials limits exposure to potential cyclical recovery upside tied to capex normalization in manufacturing.

The material exposure to financials (~18.1%) indicates a diversified approach; financials in the filing appear concentrated in large-cap banks and select asset managers, structures that respond to interest-rate trajectories and net-interest-margin trends. Given the macro backdrop in Q1 2026—where short-term rates remained elevated relative to 2024—this weight suggests a defensive tilting to high-quality banks rather than small-cap lenders. Healthcare’s 12.4% weight offers defensive ballast versus growth cyclicality, with allocations skewed toward large-cap pharma and select medical-device companies that have more predictable cash flows.

Comparatively, Eurizon SLJ’s sector mix diverges from a plain-vanilla S&P 500 portfolio: technology is slightly overweight vs the S&P 500 tech weight (~27.5% as of March 31, 2026), financials are roughly in line, and industrials are underweight. These deviations imply a blend of benchmark-aware positioning plus active convictions where the manager sees secular growth (technology) and defensive earnings stability (healthcare). For corporates, the presence of established institutional holders in the 13F can be a governance signal; for peers, it is a data point in the competitive landscape for flows and talent retention.

Risk Assessment

13F disclosures are limited: they omit short positions, cash levels, options exposure, and non-13f securities such as many foreign-listed stocks and private holdings. This structural limitation means the filing could understate net market exposure or overstate conviction in a long-only snapshot. For instance, if Eurizon SLJ increased long tech exposure while simultaneously hedging index risk via futures or options, the net systemic exposure might be meaningfully lower than the 1.23bn long value suggests. Institutional allocators should therefore treat 13F data as one input among many, not a comprehensive risk statement.

Market-cap concentration is another risk highlighted by the filing. The top-5 holdings representing close to 28% of disclosed value increases idiosyncratic risk: adverse earnings or regulatory news for one of those names could lead to concentrated mark-to-market losses. Liquidity considerations are relevant as well; while mega-cap names are liquid, any rapid deleveraging by managers collectively could amplify intraday moves in mid-cap holdings that the filing shows by number but not intraday turnover.

Macro and event risks are also present. Q2 2026 calendar events—monetary policy decisions, geopolitical developments, and earnings revisions—can alter the validity of a quarter-end 13F read quickly. The filing captures a moment of positioning that might be outdated within weeks in a fast-moving macro regime. As such, counterparties and corporate strategists must overlay real-time flow and earnings signals on top of the static 13F picture before drawing firm conclusions.

Fazen Markets Perspective

From Fazen Markets' vantage point, Eurizon SLJ’s Q1 positioning exemplifies a broader structural trend among European active managers: persistent tilt toward US mega-cap technology as a center of long-term growth exposure, accompanied by selective risk mitigation through financials and healthcare. That tilt is less a contrarian move than a convergence of consensus views—in other words, it increases tracking risk to benchmark winners rather than introducing idiosyncratic alpha. Institutional investors should be mindful that when several large managers converge on similar concentrations, systemic liquidity and repricing risk can rise if macro sentiment flips.

Contrarian nuance: a heavy common exposure to the same mega-cap names can create an opportunity for differentiated managers to exploit dispersion by rotating into underowned small- and mid-cap pockets or by using active derivatives strategies. If technology multiples compress, managers overweight in smaller, less-tracked secular growth stories—or those with stronger earnings resilience—could outperform. Conversely, the apparent preference for large-cap tech among managers like Eurizon SLJ increases the probability that index-led flows, not idiosyncratic stock selection, will dominate near-term leadership in the market.

For allocators, the practical implication is governance and liquidity monitoring: review shareholder registries in light of 13F disclosures, and probe whether managers have meaningful off-balance exposures (derivatives, shorts) that alter risk-return profiles. Fazen Markets recommends combining static 13F analysis with real-time trade and options-flow data to form a more complete view of manager intentions and potential market impact (see our equities and market research pages for methodology notes).

Outlook

Looking ahead to Q2 2026, several catalysts will test the convictions implied by the 13F. Earnings season for mega-cap technology firms, central-bank communications around policy normalization, and macro growth data will each affect how the positions reported on March 31 perform. If GDP and corporate guidance continue to show resilience, technology and select financial holdings in the filing may re-rate higher; conversely, weaker macro prints could pressure growth valuations and favor the healthcare and cash-anchored positions.

For market practitioners watching flows, the key metric will be whether flows into technology ETFs and active strategies persist at the same clip they did in Q1 2026. If those flows slow, managers with sizable tech weights—like Eurizon SLJ in this filing—could either pare exposure or re-balance within tech to more defensive software and services names. We also expect continued scrutiny of position-level liquidity as concentration increases across managers; any cluster of correlated selling could trigger temporary dislocations beyond what size-based metrics predict.

Finally, the 13F serves as a reminder that public disclosures are necessary but insufficient for full risk assessment. Investors should treat this filing as a directional input while seeking complementary, higher-frequency signals from earnings calls, options markets, and broker-traded volumes to refine positioning assumptions for Q2.

Bottom Line

Eurizon SLJ’s May 6, 2026 13F (reporting March 31, 2026) shows a concentrated, tech-tilted long book of roughly $1.23bn with material implications for sector sensitivity and liquidity. Use the filing as a directional input and combine it with real-time flow and derivatives data to assess current exposures.

Disclaimer: This article is for informational purposes only and does not constitute investment advice.